{
  "symbol": "IPSC",
  "company": "Century Therapeutics, Inc.",
  "generated_at": "2026-06-24T07:36:48.975Z",
  "event_count": 1,
  "events": [
    {
      "type": "scout_dossier",
      "ts": "2026-06-09T20:51:23.250Z",
      "summary": "The investigation was triggered by high Form 4 filing volume (3 in last 14 days), but after reading each transaction code, all recent filings are automatic tax-withholding sales from RSU vesting schedules — zero open-market discretionary purchases in the past 90 days. The CEO did receive a large options grant (945K shares at $1.84) in February, which is meaningful alignment of interests, but it is compensation, not a discretionary buy signal. Century has genuine catalysts: CNTY-813 for Type 1 Diabetes IND expected Q4 2026 with initial clinical data in H2 2027; oral presentation at ADA on June 8 showed durable glucose control >8 months and immune evasion without immunosuppression. A $135M private placement in January extended runway to Q1 2029, eliminating near-term dilution risk. However, IPSC is a pre-revenue biotech burning ~$23-24M/quarter with no product revenue and EV/EBITDA deeply negative — there is no conventional valuation framework that supports the current price on fundamentals alone.",
      "verdict": "no_anomaly",
      "confidence": 4,
      "tool_calls": 33,
      "walltime_min": 38,
      "debug_path": "dossiers/2026-06-09-IPSC.scout.debug.json"
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "IPSC",
    "call": "BUY",
    "confidence": 5,
    "score": 7,
    "factors": {
      "above_200dma": "+2",
      "above_50dma": "+1",
      "momentum_strong_up": "+2 (281.5%)",
      "rsi_neutral": "0 (57.9)",
      "macd_above_signal": "+1",
      "recent_macd_bullish_cross": "+1 (5d ago)",
      "from_high": "0 (-18.0%)"
    },
    "summary": "BUY (score +7) · 12-1 mom 281.5% · RSI 57.9 · above_both · -18.0% from high",
    "last_close": 2.41,
    "one_month_ago_close": 2.27,
    "twelve_month_ago_close": 0.6,
    "twelve_one_momentum_pct": 281.51,
    "rsi_14": 57.9,
    "ma_stack": "above_both",
    "from_period_high_pct": -18.03,
    "period_high": 2.94,
    "price_targets": {
      "bear": 1.53,
      "fair": 3.15,
      "bull": 8,
      "bear_return_pct": -36.5,
      "fair_return_pct": 30.7,
      "bull_return_pct": 232,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 2,
        "target_mean": 4.75,
        "target_high": 8,
        "analyst_count": 4
      }
    },
    "generated_at": "2026-06-24T07:36:48.971Z"
  }
}